Cigna Investments’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $793K | Sell |
2,052
-54
| -3% | -$20K | 0.1% | 159 |
|
|
2026
Q1 | $617K | Sell |
2,106
-57
| -3% | -$18.7K | 0.1% | 200 |
|
|
2025
Q4 | $758K | Sell |
2,163
-51
| -2% | -$17.2K | 0.11% | 156 |
|
|
2025
Q3 | $716K | Hold |
2,214
| – | – | 0.1% | 176 |
|
|
2025
Q2 | $861K | Sell |
2,214
-115
| -5% | -$46.3K | 0.15% | 141 |
|
|
2025
Q1 | $1.01M | Sell |
2,329
-30
| -1% | -$12K | 0.19% | 107 |
|
|
2024
Q4 | $870K | Sell |
2,359
-31
| -1% | -$13K | 0.15% | 127 |
|
|
2024
Q3 | $1.24M | Sell |
2,390
-17
| -0.7% | -$9.08K | 0.22% | 86 |
|
|
2024
Q2 | $1.3M | Sell |
2,407
-90
| -4% | -$47.6K | 0.24% | 81 |
|
|
2024
Q1 | $1.29M | Sell |
2,497
-25
| -1% | -$12.4K | 0.24% | 86 |
|
|
2023
Q4 | $1.19M | Sell |
2,522
-16
| -0.6% | -$7.4K | 0.24% | 86 |
|
|
2023
Q3 | $1.1M | Sell |
2,538
-334
| -12% | -$151K | 0.25% | 84 |
|
|
2023
Q2 | $1.28M | Sell |
2,872
-44
| -2% | -$20.3K | 0.24% | 84 |
|
|
2023
Q1 | $1.34M | Sell |
2,916
-69
| -2% | -$32.8K | 0.27% | 75 |
|
|
2022
Q4 | $1.53M | Buy |
2,985
+20
| +0.7% | +$10.2K | 0.32% | 66 |
|
|
2022
Q3 | $1.35M | Sell |
2,965
-156
| -5% | -$74.6K | 0.3% | 63 |
|
|
2022
Q2 | $1.5M | Sell |
3,121
-1,188
| -28% | -$588K | 0.3% | 68 |
|
|
2022
Q1 | $2.12M | Sell |
4,309
-1,215
| -22% | -$555K | 0.26% | 75 |
|
|
2021
Q4 | $2.56M | Sell |
5,524
-2,013
| -27% | -$847K | 0.2% | 88 |
|
|
2021
Q3 | $2.81M | Sell |
7,537
-180
| -2% | -$68.4K | 0.21% | 92 |
|
|
2021
Q2 | $2.95M | Sell |
7,717
-1,159
| -13% | -$443K | 0.21% | 91 |
|
|
2021
Q1 | $3.19M | Buy |
8,876
+111
| +1% | +$35.7K | 0.22% | 92 |
|
|
2020
Q4 | $2.81M | Buy |
8,765
+559
| +7% | +$172K | 0.22% | 90 |
|
|
2020
Q3 | $2.2M | Sell |
8,206
-799
| -9% | -$215K | 0.21% | 93 |
|
|
2020
Q2 | $2.37M | Buy |
9,005
+1,777
| +25% | +$474K | 0.22% | 89 |
|
|
2020
Q1 | $1.64M | Buy |
7,228
+460
| +7% | +$125K | 0.21% | 102 |
|
|
2019
Q4 | $1.79M | Sell |
6,768
-859
| -11% | -$236K | 0.19% | 116 |
|
|
2019
Q3 | $2.05M | Buy |
7,627
+400
| +6% | +$110K | 0.21% | 100 |
|
|
2019
Q2 | $2.13M | Sell |
7,227
-288
| -4% | -$78.7K | 0.23% | 89 |
|
|
2019
Q1 | $2.16M | Sell |
7,515
-175
| -2% | -$50.6K | 0.24% | 83 |
|
|
2018
Q4 | $2.02M | Buy |
7,690
+32
| +0.4% | +$8.8K | 0.17% | 83 |
|
|
2018
Q3 | $2.11M | Sell |
7,658
-2,236
| -23% | -$580K | 0.17% | 86 |
|
|
2018
Q2 | $2.35M | Sell |
9,894
-1,204
| -11% | -$279K | 0.17% | 84 |
|
|
2018
Q1 | $2.44M | Sell |
11,098
-132
| -1% | -$31K | 0.16% | 88 |
|
|
2017
Q4 | $2.53M | Sell |
11,230
-626
| -5% | -$133K | 0.17% | 86 |
|
|
2017
Q3 | $2.25M | Buy |
11,856
+1,579
| +15% | +$301K | 0.15% | 95 |
|
|
2017
Q2 | $1.93M | Sell |
10,277
-616
| -6% | -$111K | 0.13% | 117 |
|
|
2017
Q1 | $1.8M | Buy |
10,893
+1,134
| +12% | +$180K | 0.12% | 129 |
|
|
2016
Q4 | $1.4M | Buy |
+9,759
| New | +$1.31M | 0.15% | 158 |
|
Other funds holding ELV
Cigna Investments's ELV Position: Q2 2026 in Review
Cigna Investments reduced its Elevance Health (ELV) stake by 2.6% in Q2 2026, selling an estimated $20K and leaving 2,052 shares worth $793K. The position accounts for 0.1% of the portfolio, ranked #159.
Cigna Investments first reported a position in ELV in Q4 2016 and has held it in 39 quarters since. The position peaked at $3.19M in Q1 2021. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Cigna Investments held 2,052 shares of Elevance Health worth $793K as of Q2 2026.
- Cigna Investments sold 54 Elevance Health shares in Q2 2026, an estimated $20K.
- Elevance Health made up 0.1% of Cigna Investments's portfolio in Q2 2026, its #159 holding.
- Cigna Investments first reported a position in Elevance Health in Q4 2016 and has held it in 39 quarters since.
- Cigna Investments's Elevance Health position peaked at $3.19M in Q1 2021.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.